BTIG analyst Ryan Zimmerman upgraded GE HealthCare stock to Buy from Hold. His new price target is $100, implying about 15% ...

GE HealthCare was spun out of GE in early 2023. As part of the separation, GE, which is now GE Aerospace, retained almost 20% ...

GE HealthCare Technologies has shown promising performance, with a 12% stock increase since June. Read why I continue to rate ...

The deal to acquire MIM Software earlier this year is bearing fruit for the Chicago-based medical device company, which sees ...

GE HealthCare (Nasdaq: GEHC) announced today that it launched its enhanced Venue Sprint point-of-care ultrasound system ...

The clearance adds a Centiloid scale tool to GE Healthcare’s Mim software to help clinicians determine the density of amyloid plaque.

The GE HealthCare imaging tool is coming out as pharma companies release new therapies onto the market to help treat the ...

GE Healthcare Technologies Inc (GEHC – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today.

GE HealthCare Technologies’ GEHC MIM Software recently announced the receipt of FDA clearance for performing Centiloid ...

Analyst Craig Bijou from Bank of America Securities reiterated a Hold rating on GE Healthcare Technologies Inc (GEHC – Research Report) ...

周三，BTIG分析师宣布将GE HealthCare Technologies Inc. (NASDAQ: GEHC)的评级从中性上调至买入，新目标价为100.00美元。这一上调是在2024年上半年充满挑战之后做出的，特别是考虑到中国市场动态对公司业绩产生的负面影响。尽管如此，分析师认为公司在下半年将迎来有利局面。 该公司已调整了2024全年指引，在第二季度财报电话会议上承认中国市场下滑超过20% ...

GE HealthCare’s recently acquired MIM Software division has secured an FDA clearance for a tool to help quantify the density ...